NeuMoDx Molecular Revenue and Competitors
Estimated Revenue & Valuation
- NeuMoDx Molecular's estimated annual revenue is currently $22.1M per year.
- NeuMoDx Molecular received $20.0M in venture funding in May 2016. 0
- NeuMoDx Molecular's total funding is $66M.
NeuMoDx Molecular Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is NeuMoDx Molecular?
Number of Employees
Employee Growth %
NeuMoDx Molecular News
NeuMoDx Molecular, Inc., an Ann Arbor, MI-based diagnostics company developing a new platform for high throughput, low cost molecular testing, raised $21m in Series B financing. The round was led by Pfizer Ventures with participation from Baird Capital, Venture Investors and existing investors ...
Baird Capital co-led a $21 million Series B financing in NeuMoDx Molecular Inc., a diagnostics company developing a new platform for high-efficiency, low-cost molecular testing. “Molecular diagnostic testing continues to be an attractive investment area for us and we look forward to working with ...
Becton Dickinson (NYSE:BDX) and subsidiaries HandyLab and GeneOhm Sciences Canada have filed a lawsuit against diagnostics company NeuMoDx, claiming patent infringement. BD acquired small diagnostics company HandyLab (Ann Arbor, Mich.) in 2009 for $275 million. HandyLab was developing bench-top ...
NEW YORK – NeuMoDx has filed a response with the District of ... by Becton Dickinson that the molecular diagnostics developer infringed on ...
18.104.22.168.1.1 Lab-on-a-chip and Molecular Biology ... Cancer Therapy; QIAGEN NV Selects NeuMoDx Molecular, Inc for CE-IVD Assays Purchase ...
BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx Molecular, Inc. today announced an expansion ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|
NeuMoDx Molecular Funding